BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10620865)

  • 1. A benefit-cost analysis of syringe exchange programs.
    Reid RJ
    J Health Soc Policy; 2000; 11(4):41-57. PubMed ID: 10620865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syringe exchange in the United States: a national level economic evaluation of hypothetical increases in investment.
    Nguyen TQ; Weir BW; Des Jarlais DC; Pinkerton SD; Holtgrave DR
    AIDS Behav; 2014 Nov; 18(11):2144-55. PubMed ID: 24824043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of syringe exchange as an HIV prevention strategy.
    Laufer FN
    J Acquir Immune Defic Syndr; 2001 Nov; 28(3):273-8. PubMed ID: 11694836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An economic analysis of needle exchange and pharmacy-based programs to increase sterile syringe availability for injection drug users.
    Lurie P; Gorsky R; Jones TS; Shomphe L
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S126-32. PubMed ID: 9663635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is your syringe services program cost-saving to society? A methodological case study.
    Des Jarlais DC; Feelemyer J; McKnight C; Knudtson K; Glick SN
    Harm Reduct J; 2021 Dec; 18(1):126. PubMed ID: 34876135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic analysis at the global level: a resource requirement model for HIV prevention in developing countries.
    Broomberg J; Söderlund N; Mills A
    Health Policy; 1996 Oct; 38(1):45-65. PubMed ID: 10160163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating the cost-effectiveness of needle-syringe programs in Australia.
    Kwon JA; Anderson J; Kerr CC; Thein HH; Zhang L; Iversen J; Dore GJ; Kaldor JM; Law MG; Maher L; Wilson DP
    AIDS; 2012 Nov; 26(17):2201-10. PubMed ID: 22914579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is Vancouver Canada's supervised injection facility cost-saving?
    Pinkerton SD
    Addiction; 2010 Aug; 105(8):1429-36. PubMed ID: 20653622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Operating needle exchange programmes in the hills of Thailand.
    Gray J
    AIDS Care; 1995; 7(4):489-99. PubMed ID: 8547363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syringe exchange programs --- United States, 2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Nov; 59(45):1488-91. PubMed ID: 21085091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using cost-effectiveness/cost-benefit analysis to allocate health resources: a level playing field for prevention?
    Phillips KA; Hotlgrave DR
    Am J Prev Med; 1997; 13(1):18-25. PubMed ID: 9037338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doing harm reduction better: syringe exchange in the United States.
    Des Jarlais DC; McKnight C; Goldblatt C; Purchase D
    Addiction; 2009 Sep; 104(9):1441-6. PubMed ID: 19215605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Syringe-exchange programs and HIV prevention: if they're effective, what's the controversy?
    Villarreal H; Fogg C
    Am J Nurs; 2006 May; 106(5):58-63; quiz 63-4. PubMed ID: 16639248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Economic evaluation of needle and syringe exchange in two provinces of Southwest China].
    Xue H; Hu Y; Sun J
    Zhonghua Yu Fang Yi Xue Za Zhi; 2014 Apr; 48(4):291-5. PubMed ID: 24969453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Needle exchange programs: an economic evaluation of a local experience.
    Gold M; Gafni A; Nelligan P; Millson P
    CMAJ; 1997 Aug; 157(3):255-62. PubMed ID: 9269195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal investment in a portfolio of HIV prevention programs.
    Zaric GS; Brandeau ML
    Med Decis Making; 2001; 21(5):391-408. PubMed ID: 11575489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Decentralization, AIDS, and harm reduction: the implementation of public policies in Rio de Janeiro, Brazil].
    Fonseca EM; Nunn A; Souza-Junior PB; Bastos FI; Ribeiro JM
    Cad Saude Publica; 2007 Sep; 23(9):2134-44. PubMed ID: 17700948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost effectiveness of SEPs.
    Makulowich GS
    AIDS Patient Care STDS; 1998 Feb; 12(2):151-2. PubMed ID: 11361923
    [No Abstract]   [Full Text] [Related]  

  • 19. Economic and Policy Analytic Approaches to Inform the Acceleration of HIV Prevention in the United States: Future Directions for the Field.
    Martin EG; Rosenberg ES; Holtgrave DR
    AIDS Educ Prev; 2018 Jun; 30(3):199-207. PubMed ID: 29969310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Syringe exchange programs--United States, 2005.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Nov; 56(44):1164-7. PubMed ID: 17989646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.